NCT06498284View on ClinicalTrials.gov

Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 25, 2024

Primary Completion Date

September 6, 2024

Study Completion Date

September 6, 2024

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

HM-002-1005

HM-002-1005 extended release tablets for oral administration compared with matching placebo tablets

Trial Locations (1)

33014

Clinical Pharmacology of Miami, Hialeah

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT06498284 - Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter